LEANNE HEDGES: Open Payments
NPI 1346470036 · ELDERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 10 payments from 8 companies in 2025. Trend: 2023 $451 · 2024 $386 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $57 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Biogen, Inc. | 1 | $27 |
| Bausch Health US, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: QULIPTA, CAPVAXIVE, QALSODY, APLENZIN, TRELEGY ELLIPTA, XIFAXAN, Cologuard Collection Kit, Wegovy.
Industry payments across MD — which companies pay providers there.
